PHS
WAT icon

PFM Health Sciences’s Waters Corp WAT Stock Holding History

PFM Health Sciences’s Portfolio WAT Stock Details WAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4M Buy
59,825
+20,062
+50% +$6.84M 1.93% 14
2026
Q1 		$11.8M Sell
39,763
-3,445
-8% -$1.18M 1.08% 31
2025
Q4 		$16.4M Buy
43,208
+12,457
+41% +$4.58M 1.64% 22
2025
Q3 		$9.22M Sell
30,751
-12,338
-29% -$3.72M 0.71% 41
2025
Q2 		$15M Sell
43,089
-8,769
-17% -$3.01M 1.28% 26
2025
Q1 		$19.1M Sell
51,858
-7,195
-12% -$2.79M 1.39% 25
2024
Q4 		$21.9M Buy
59,053
+7,990
+16% +$2.92M 1.36% 24
2024
Q3 		$18.4M Buy
51,063
+30,522
+149% +$9.94M 1.04% 30
2024
Q2 		$5.96M Sell
20,541
-17,923
-47% -$5.72M 0.29% 54
2024
Q1 		$13.2M Buy
+38,464
New +$12.6M 0.62% 48
2023
Q3 		– Sell
-94,624
Closed -$25.2M – 87
2023
Q2 		$25.2M Hold
94,624
– – 0.98% 41
2023
Q1 		$29.3M Hold
94,624
– – 1.29% 34
2022
Q4 		$32.4M Sell
94,624
-23,010
-20% -$7.28M 1.16% 38
2022
Q3 		$31.7M Hold
117,634
– – 1.15% 40
2022
Q2 		$38.9M Hold
117,634
– – 1.49% 27
2022
Q1 		$36.5M Hold
117,634
– – 1.37% 34
2021
Q4 		$43.8M Hold
117,634
– – 1.49% 31
2021
Q3 		$42M Hold
117,634
– – 1.24% 36
2021
Q2 		$40.7M Buy
117,634
+4,545
+4% +$1.44M 1.27% 31
2021
Q1 		$32.1M Buy
113,089
+18,592
+20% +$5.08M 0.98% 40
2020
Q4 		$23.4M Buy
+94,497
New +$21.4M 0.82% 49
2013
Q4 		– Sell
-43,054
Closed -$4.57M – 78
2013
Q3 		$4.57M Buy
43,054
+1,199
+3% +$123K 0.11% 67
2013
Q2 		$4.19M Buy
+41,855
New +$4.01M 0.09% 66

Other funds holding WAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PFM Health Sciences's WAT Position: Q2 2026 in Review

PFM Health Sciences increased its Waters Corp (WAT) stake by 50% in Q2 2026, buying an estimated $6.84M and bringing the position to 59,825 shares worth $22.4M. The position accounts for 1.93% of the portfolio, ranked #14.

PFM Health Sciences first reported a position in WAT in Q2 2013 and has held it in 23 quarters since. The position peaked at $43.8M in Q4 2021. 1,179 funds tracked by Wall St. Rank hold WAT as of Q2 2026.

  • PFM Health Sciences held 59,825 shares of Waters Corp worth $22.4M as of Q2 2026.
  • PFM Health Sciences bought 20,062 Waters Corp shares in Q2 2026, an estimated $6.84M.
  • Waters Corp made up 1.93% of PFM Health Sciences's portfolio in Q2 2026, its #14 holding.
  • PFM Health Sciences first reported a position in Waters Corp in Q2 2013 and has held it in 23 quarters since.
  • PFM Health Sciences's Waters Corp position peaked at $43.8M in Q4 2021.
  • 1,179 funds tracked by Wall St. Rank held Waters Corp as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.